Paul Peter Tak is Chief Executive Officer of Candel Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Candel Therapeutics, Inc.
30 Nov 23
4
Candel Therapeutics, Inc.
28 Nov 23
4
Candel Therapeutics, Inc.
2 May 23
4
Candel Therapeutics, Inc.
12 Dec 22
4
Candel Therapeutics, Inc.
30 Nov 22
4
Candel Therapeutics, Inc.
1 Mar 22
4
Candel Therapeutics, Inc.
2 Aug 21
3
Candel Therapeutics, Inc.
26 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Nov 23 | CADL Candel Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 0.9 | 43,443 | 39.10 k | 373,556 |
26 Nov 23 | CADL Candel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 180,108 | 0.00 | 416,999 |
28 Apr 23 | CADL Candel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.29 | 180,000 | 232.20 k | 180,000 |
9 Dec 22 | CADL Candel Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.92 | 12,935 | 24.84 k | 40,985 |
8 Dec 22 | CADL Candel Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.7 | 3,050 | 5.19 k | 28,050 |
28 Nov 22 | CADL Candel Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 195,906 | 0.00 | 220,906 |